These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23255662)

  • 1. Glucocorticoid excess and disturbed hemodynamics in advanced age: the extent to which soy isoflavones may be beneficial.
    Ajdžanović VZ; Milošević VLj; Spasojević IB
    Gen Physiol Biophys; 2012 Dec; 31(4):367-74. PubMed ID: 23255662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
    McCarty MF
    Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytoestrogens and cardiovascular disease.
    Cassidy A; Hooper L
    J Br Menopause Soc; 2006 Jun; 12(2):49-56. PubMed ID: 16776855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women.
    Garrido A; De la Maza MP; Hirsch S; Valladares L
    Maturitas; 2006 Jun; 54(3):270-6. PubMed ID: 16414215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The study of soy isoflavone metabolism in patients with cardiovascular diseases].
    Tutel'ian VA; Pavliuchkova MS; Pogozheva AV; Vorob'eva LSh; Derbeneva SA
    Vopr Pitan; 2002; 71(4):20-2. PubMed ID: 12462950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulative actions of dietary soy isoflavone on biological antioxidative system and lipid metabolism in rats.
    Kawakami Y; Tsurugasaki W; Yoshida Y; Igarashi Y; Nakamura S; Osada K
    J Agric Food Chem; 2004 Mar; 52(6):1764-8. PubMed ID: 15030243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of soy isoflavones on α-amylase activity, insulin deficiency, liver-kidney function and metabolic disorders in diabetic rats.
    Hamden K; Jaouadi B; Carreau S; Aouidet A; Elfeki A
    Nat Prod Res; 2011 Feb; 25(3):244-55. PubMed ID: 21108110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doenjang, a fermented soybean paste, decreased visceral fat accumulation and adipocyte size in rats fed with high fat diet more effectively than nonfermented soybeans.
    Kwak CS; Park SC; Song KY
    J Med Food; 2012 Jan; 15(1):1-9. PubMed ID: 22082067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered testicular microsomal steroidogenic enzyme activities in rats with lifetime exposure to soy isoflavones.
    McVey MJ; Cooke GM; Curran IH
    J Steroid Biochem Mol Biol; 2004 Dec; 92(5):435-46. PubMed ID: 15698548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones and cognitive function.
    Lee YB; Lee HJ; Sohn HS
    J Nutr Biochem; 2005 Nov; 16(11):641-9. PubMed ID: 16169201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial.
    Ye YB; Wang ZL; Zhuo SY; Lu W; Liao HF; Verbruggen M; Fang S; Mai HY; Chen YM; Su YX
    Menopause; 2012 Jul; 19(7):791-8. PubMed ID: 22278344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review.
    Ricketts ML; Moore DD; Banz WJ; Mezei O; Shay NF
    J Nutr Biochem; 2005 Jun; 16(6):321-30. PubMed ID: 15936643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome.
    Wang M
    Curr Opin Investig Drugs; 2006 Apr; 7(4):319-23. PubMed ID: 16625818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and benefits of dietary isoflavones for cancer.
    Andres S; Abraham K; Appel KE; Lampen A
    Crit Rev Toxicol; 2011 Jul; 41(6):463-506. PubMed ID: 21438720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of soy isoflavones on obesity.
    Ørgaard A; Jensen L
    Exp Biol Med (Maywood); 2008 Sep; 233(9):1066-80. PubMed ID: 18535167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Soya isoflavones and evidences on cardiovascular protection].
    González Cañete N; Durán Agüero S
    Nutr Hosp; 2014 Jun; 29(6):1271-82. PubMed ID: 24972463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy isoflavones in the management of postmenopausal osteoporosis.
    Atmaca A; Kleerekoper M; Bayraktar M; Kucuk O
    Menopause; 2008; 15(4 Pt 1):748-57. PubMed ID: 18277912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of adiponectin secretion by soy isoflavones has implication for endocrine function of the testis.
    Pfaehler A; Nanjappa MK; Coleman ES; Mansour M; Wanders D; Plaisance EP; Judd RL; Akingbemi BT
    Toxicol Lett; 2012 Feb; 209(1):78-85. PubMed ID: 22155228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of nutritional antioxidants for the correction of metabolic disorders of cardiovascular patients].
    Peresadina VR; Dmitrievskaia MN; Mal'tsev GIu; Pogozheva AV; Vasil'ev AV
    Vopr Pitan; 2004; 73(3):3-6. PubMed ID: 15335019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy.
    Dijsselbloem N; Vanden Berghe W; De Naeyer A; Haegeman G
    Biochem Pharmacol; 2004 Sep; 68(6):1171-85. PubMed ID: 15313415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.